Complete

A new way to diagnose and prevent squamous cell carcinoma

Cancer types:

Skin cancer

Project period:

Research institute:

New York University

Award amount:

£194,081

Location:

USA

Researcher Dr Markus Schober

Dr Markus Schober aims to work out how cells rewire their internal programs into a state that helps them turn into cancer cells. 

Meet the scientist

Markus is Assistant Professor in the Department of Biology at New York University in the United States. His expertise in understanding how cancer cells function has led to key discoveries.

The science

Squamous cell carcinoma (SCC) is a group of cancers that originate in cells forming the surface of the skin and lining the internal walls of our organs, respiratory tract and digestive tract. Collectively, these cancers represent the second largest number of cancers worldwide. Many of these cancers are treated successfully in the early stages of the disease, but if diagnosed late, SCC can be much more aggressive and difficult to treat. 

Dr Markus Schober is uncovering the molecular secrets that allow healthy cells to make the switch to becoming SCC cells. Once revealed, this knowledge could lead to new ways to improve the early diagnosis and prevention of SCC. 

Related projects

Complete USA

Skin cancer

How do some skin cancer cells become resistant to treatment?

This project hopes to discover how skin cancer develops resistance to treatments and find ways to overcome it so that survival rates improve.

Researcher: Dr Bin Zheng

Overcoming drug resistance in skin cancer
Alfonso Calvo Team

Active Spain

Lung cancer

Can we stop cancers hiding from immunotherapy?

This project hopes to find a way for immunotherapies to work better, for more cancer patients. Using cutting-edge technologies they will test out a potential new way to treat cancer and explore how to advance it towards the clinic. 

Researcher: Dr Alfonso Calvo

Can we stop cancers hiding from immunotherapy?

Active USA

Prostate cancer

Can we use ‘minibodies’ to detect and treat cancer?

This project hopes to develop a new way to identify and target prostate and breast cancer cells in the body using tiny molecular ‘flags’, called minibodies. 

Researcher: Dr Tanya Stoyanova

Mini but mighty: Using ‘minibodies’ to detect and treat prostate cancer
Share this page